Prevention of migraine recurrence using a 5-HT1B/1D receptor agonist such as eletriptan and pharmaceutical composition thereof

摘要

A pharmaceutical composition comprising eletriptan, or a pharmaceutically acceptable salt thereof, use of eletriptan for the manufacture of a medicament for the prevention of migraine recurrence and the use of a 5-HT1B/1D receptor agonist, or a pharmaceutically acceptable salt or composition thereof, for the manufacture of a dual-, sustained-, delayed-, controlled- or pulsed-release pharmaceutical composition for the prevention of migraine recurrence is disclosed. (62) Divided out of 508736